Download video

STREAM trial: enzalutamide and androgen deprivation therapy with salvage radiation in men with h...

121 views

ecancer

5 years ago

STREAM trial: enzalutamide and androgen deprivation therapy with salvage radiation in men with h...

STREAM trial: enzalutamide and androgen deprivation therapy with salvage radiation in men with h...

STREAM trial: enzalutamide and androgen deprivation therapy with salvage radiation in men with h...
1:46
STREAM trial: enzalutamide and androgen deprivation therapy with salvage radiation in men with h...
by ecancer
News from the STREAM trial: salvage radiation with enzalutamide and ADT
1:55
News from the STREAM trial: salvage radiation with enzalutamide and ADT
by VJOncology
Enzalutamide + ADT in Men with De Novo mHSPC: The ARCHES Trial
5:11
Enzalutamide + ADT in Men with De Novo mHSPC: The ARCHES Trial
by Grand Rounds in Urology
ARCHES trial: androgen deprivation therapy with enzalutamide or placebo in mHSPC
3:43
ARCHES trial: androgen deprivation therapy with enzalutamide or placebo in mHSPC
by ecancer
ARCHES trial overview: ADT plus enzalutamide for metastatic hormone-sensitive prostate cancer
1:55
ARCHES trial overview: ADT plus enzalutamide for metastatic hormone-sensitive prostate cancer
by VJOncology
Role of ADT with Radiation
8:59
Role of ADT with Radiation
by Grand Rounds in Urology
Andrew Armstrong, MD, discusses the Phase 2 STREAM study in pre-metastatic prostate cancer
1:18
Andrew Armstrong, MD, discusses the Phase 2 STREAM study in pre-metastatic prostate cancer
by OBRoncology
Updated overall survival outcomes in ENZAMET (ANZUP 1304)
6:40
Updated overall survival outcomes in ENZAMET (ANZUP 1304)
by European Association of Urology
SPPORT: ADT and salvage radiotherapy in prostate cancer
2:24
SPPORT: ADT and salvage radiotherapy in prostate cancer
by VJOncology
SALV-ENZA: SRT + enzalutamide in high-risk PSA-recurrent prostate cancer after radical prostatectomy
3:07
SALV-ENZA: SRT + enzalutamide in high-risk PSA-recurrent prostate cancer after radical prostatectomy
by VJOncology
Enzalutamide plus androgen deprivation therapy prolongs survival in men with metastatic hormone-...
6:06
Enzalutamide plus androgen deprivation therapy prolongs survival in men with metastatic hormone-...
by ecancer
Androgen Deprivation Therapy Plus Enzalutamide for Hormone-Sensitive Prostate Cancer
3:13
Androgen Deprivation Therapy Plus Enzalutamide for Hormone-Sensitive Prostate Cancer
by PracticeUpdate
Update on ARCHES trial: implications for prostate cancer treatment
3:57
Update on ARCHES trial: implications for prostate cancer treatment
by VJOncology
Future research on SRT plus enzalutamide for PSA recurrent high-risk prostate cancer
0:48
Future research on SRT plus enzalutamide for PSA recurrent high-risk prostate cancer
by VJOncology
RADICALS-HD trial: androgen deprivation therapy with post-operative radiotherapy to treat prosta...
3:13
RADICALS-HD trial: androgen deprivation therapy with post-operative radiotherapy to treat prosta...
by ecancer
Enzalutamide as treatment for men with mHSPC who have received testosterone suppression
3:38
Enzalutamide as treatment for men with mHSPC who have received testosterone suppression
by ecancer
ASCO GU 2019 - Dr. Andrew J. Armstrong, Duke University, NC, USA
2:29
ASCO GU 2019 - Dr. Andrew J. Armstrong, Duke University, NC, USA
by Oncology Information Group
ARCHES trial: enzalutamide plus ADT for mHSPC
2:37
ARCHES trial: enzalutamide plus ADT for mHSPC
by VJOncology
Update on the ARCHES Trial: New Indication for Enzalutamide in mHSPC
6:02
Update on the ARCHES Trial: New Indication for Enzalutamide in mHSPC
by Grand Rounds in Urology
PCa Commentary: Sequencing Bipolar Androgen Therapy (BAT) with Xtandi-  An Effective Option
10:07
PCa Commentary: Sequencing Bipolar Androgen Therapy (BAT) with Xtandi-  An Effective Option
by Grand Rounds in Urology